Life Sciences Company

Ashley DeFlice, Regulatory Affairs Specialist at wholesale distributor Henry Schein, explains why pharmaceutical manufacturers must act with urgency…

When the final phase of the U.S. Drug Supply Chain Security Act (DSCSA) goes into effect on November 27, 2023, it will mandate significantly expanded…

Manage all global track-and-trace mandates with a proven serialization solution suite used by more than 80% of pharmaceutical companies launching…

Global challenges are forcing leaders to rethink how they manage supply chains—and specifically how they work with partners.

Manage all global track-and-trace mandates with a scalable and flexible serialization solution delivered on the industry-leading supply chain network…

Integrate once, interoperate with all customers to collaboratively resolve DSCSA exceptions.

As a pharmaceutical manufacturer, you know that complying with DSCSA 2023 is important for your own operations

Learn why digital supply networks and collective intelligence have emerged as the newest weapons in the battle against drug shortages.

Poor visibility and a lack of interoperability with key suppliers are two of the leading drivers of supply chain disruption—and the Internet of…

DSCSA 2023 introduces significant regulatory compliance challenges and new operational complexities for drug manufacturers.

How to Ensure Drug Supply and Create Business Value with DSCSA Compliance for Manufacturers & Wholesale Distributors

Integrate and interoperate with all suppliers on the Internet of Pharmaceutical Supply Chains.